Search results
Earnings call: IceCure reports 30% increase in Q1 product sales
Investing.com· 6 days agoThe company’s ICE3 study on breast cancer treatment has been submitted to the FDA for marketing...
Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By...
Investing.com· 5 days agoIn their first quarter 2024 earnings call, Cellectis, a biopharmaceutical company, presented a...
Earnings call: Build-A-Bear Workshop faces revenue dip, stays optimistic By Investing.com
Investing.com· 4 days agoBuild-A-Bear Workshop, Inc. (BBW) reported a decline in revenue for the first quarter of 2024, with...
BioHarvest Sciences Reports First Quarter 2024 Financial Results
Digital Journal· 5 days agoVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)("BioHarvest" or the "Company"), a company pioneering its ...